Pioneering
Breakthrough
Treatments for Neurodegenerative Disease
We’re bringing new hope to millions affected by Alzheimer’s, ALS, and other neurodegenerative diseases.
Advancing the Future of Neurodegenerative Treatment
At KeifeRx, we’re revolutionizing the approach to treating neurodegenerative diseases through innovative science, targeted therapies, and a commitment to patient well-being. Our groundbreaking research and development pipeline represents a new era in neurological medicine.
Pioneering Next-Generation Therapeutics
Through innovative kinase inhibitor technology, we're developing breakthrough treatments that cross the blood-brain barrier to address the root causes of neurodegenerative diseases.
Transforming Lives Through Innovation
We're dedicated to bringing hope to millions affected by neurodegenerative and immune diseases. Our treatments aim to restore cellular function, remove toxic proteins, and ultimately improve patient wellbeing and quality of life.
Advancing Multiple Treatment Pathways
Our robust pipeline includes targeted therapies for Alzheimer's, ALS, Parkinson's, and frontotemporal dementia. We're also expanding into inflammatory conditions like MCAS and Lyme disease, offering new hope across multiple disease states.
Backed by Clinical Excellence
Building on extensive clinical experience and partnerships with leading institutions like Georgetown University, we're developing second-generation compounds that represent the future of neurodegenerative disease treatment.